Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00661154 · ClinicalTrials.gov registry record
Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project
A clinical trial, sponsored by Stanford University.
- Completed
- Registry status
- 7
- Enrollment target
NCT00661154: Completed study, sponsored by Stanford University.
NCT00661154 is a clinical trial that has completed, run by Stanford University. The registered enrollment target is 7 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00661154 has completed, sponsored by Stanford University.
- COMPLETED
- Registry status
- 7 participants
- Enrollment target
Study Summary
To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maximize the chemotherapy delivery into the tumor for improved cancer treatment.
Interventions
- DRUG Bevacizumab
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 7 participants |
| Start Date | 2008-02 |
| Est. Completion | 2010-07 |
What the finished NCT00661154 record still lists
NCT00661154 is an observational study that tracks outcomes without assigning an intervention. The registry caps enrollment at 7 participants, a relatively small participant target.
The record links to 0 conditions, and to 1 intervention - of which Bevacizumab is the first listed.
NCT00661154 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT00661154 about?
NCT00661154 is a clinical study titled "Avastin/[18-F]-5-fluorouracil PET/CT Imaging Feasibility Project". To determine whether using a radiolabelled analog of 5-FU, \[18F\]-5-fluorouracil, for PET/CT imaging can visually demonstrate differential chemotherapy delivery to known tumor sites before and after administration of bevacizumab and determine the optimal timing of bevacizumab administration to maxi...
What is the current status of trial NCT00661154?
This trial is currently completed. The enrollment target is 7 participants. The study started on 2008-02. Estimated completion is 2010-07.
What interventions are being tested in trial NCT00661154?
The interventions under investigation include: Bevacizumab (DRUG).
Who is sponsoring clinical trial NCT00661154?
This trial is sponsored by Stanford University, which has 1,744 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia